3 patents
Utility
Combination Therapy for Treating MPS1
4 May 23
The application is directed to compounds of formula (I) and their salts and solvates, wherein B, R1, R2, R3, R3’, R4, R4’ and R5 are as set forth in the specification, as well as to methods for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of, e.g., MPS1, optionally in combination with α-L-iduronidase or an analog or variant thereof, e.g., laronidase.
Ana Maria GARCÍA COLLAZO, Elena CUBERO JORDÀ, Xavier BARRIL ALONSO, Roberto MAJ, Natalia PEREZ CARMONA
Filed: 3 Feb 21
Utility
Heteroaryl Compounds and Therapeutic Uses Thereof In Conditions Associated with the Alteration of the Activity of Beta-glucocerebrosidase
6 Apr 23
Ana Maria GARCÍA COLLAZO, Elena CUBERO JORDÀ, Manolo BELLOTTO, Enrique FERNÁNDEZ IGLESIAS
Filed: 25 Nov 20
Utility
Aryl and Heteroaryl Compounds, and Therapeutic Uses Thereof In Conditions Associated with the Alteration of the Activity of Galactocerebrosidase
23 Feb 23
Ana Maria GARCÍA COLLAZO, Elena CUBERO JORDÀ, Xavier BARRIL ALONSO, Manolo BELLOTTO
Filed: 25 Nov 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first